Efficacy, Safety and Responder Subanalysis of Lenalidomide in Heavily Pretreated, Relapsed/Refractory Patients With Mantle Cell Lymphoma Post-Bortezomib: Phase II MCL-001 "EMERGE" Study

Yazar
Cicero, Sherri
Besisik, Sevgi
Zhang, Lei
Fu, Tommy
Witzig, Thomas
Goy, Andre
Williams, Michael E.
Drach, Johannes
Ramchandren, Radhakrishnan
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/113883
https://doi.org/10.1016/j.clml.2014.06.077
Koleksiyonlar